prof. MUDr. Alexandr Poprach, Ph.D.
Professor, Comprehensive Cancer Care Department
Total number of publications: 171
2025
-
Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2<sup>EV</sup> study
CLINICAL & EXPERIMENTAL METASTASIS, year: 2025, volume: 42, edition: 2, DOI
-
DIA-MS identified transmembrane glycoprotein GPNMB as a candidate predictive biomarker and potentially a therapeutic target in metastatic renal cell carcinoma
Year: 2025, type: Conference abstract
-
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma : A Multicenter Real-World Analysis of the ARON-2EV Cohort
EUROPEAN UROLOGY OPEN SCIENCE, year: 2025, volume: 82, edition: December 2025, DOI
-
Exploring motivations and barriers in prostate cancer screening: lessons from a volunteer-based MRI screening study
Frontiers in Public Health, year: 2025, volume: 13, edition: November 2025, DOI
-
Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial
Lancet Oncology, year: 2025, volume: 26, edition: 4, DOI
-
Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study
EUROPEAN UROLOGY FOCUS, year: 2025, volume: 11, edition: 5, DOI
-
Impact of concomitant use of proton pump inhibitors or cardiovascular medication on survival outcomes of patients with metastatic renal cell carcinoma treated with nivolumab
CLINICAL & EXPERIMENTAL METASTASIS, year: 2025, volume: 42, edition: 5, DOI
-
Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, year: 2025, volume: 17, edition: May 2025, DOI
-
ProstaPilot: A Comparative Study of Biparametric Magnetic Resonance Imaging Versus Prostate-specific Antigen as a Screening Test for Prostate Cancer
EUROPEAN UROLOGY OPEN SCIENCE, year: 2025, volume: 76, edition: June 2025, DOI
-
Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience
Cancer Medicine, year: 2025, volume: 14, edition: 4, DOI